Gate
About the company
Cenesy AB focuses on fundamental research in clinical neuroschience aiming at developing safety products to protect the head and neck from being injured following an impact. The products, defined as Propretech, focus on helmets, caps and head bands based on results from fundamental research analysis.
Quick links:
Contact:
Hans von Holst, CEO, Founder
hvh@cenesy.com
+46702390067
Capital need and valuation:
Capital sought: 2 MSEK
Round type: Seed
Premoney evaluation: To be discussed.
Intended use of Funds: Product and technology development
Financial forecast
Projected revenue: 2026: xx Euro.
Revenue model: Licensing
Primary value drivers: Pricing
Traction and previous funding
Founder investment: 4 MSEK
External Capital Raised: 0 SEK
Vision and impact
The company hopes to become one potential leder of the improvement
of safetyness to the nervous system with its present and future sustainable products.
Risk management
The market is not yet ready for the improved products developed by Cenesy AB and, hence, this will take a longer time to get access to the market. Also, at present Cenesy AB are at the moment preparing for CE marketing of two products.